FI69474C - Foerfarande att framstaella anti-inflammatoriska 6alfa-fluor-9alfa-klor-prednisolon 17,21-diestrar - Google Patents
Foerfarande att framstaella anti-inflammatoriska 6alfa-fluor-9alfa-klor-prednisolon 17,21-diestrar Download PDFInfo
- Publication number
- FI69474C FI69474C FI803578A FI803578A FI69474C FI 69474 C FI69474 C FI 69474C FI 803578 A FI803578 A FI 803578A FI 803578 A FI803578 A FI 803578A FI 69474 C FI69474 C FI 69474C
- Authority
- FI
- Finland
- Prior art keywords
- acetate
- fluoro
- chloro
- epoxy
- dione
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
- C07J71/0015—Oxiranes at position 9(11)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT7927353A IT1209140B (it) | 1979-11-16 | 1979-11-16 | 6 alfa-fluoro-prednisolone 17,21-diesteri. |
IT2735379 | 1979-11-16 | ||
IT4985380 | 1980-10-09 | ||
IT49853/80A IT1143039B (it) | 1980-10-09 | 1980-10-09 | 6-alfa-fluoro-prednisolone 17,21-diesteri |
Publications (3)
Publication Number | Publication Date |
---|---|
FI803578L FI803578L (fi) | 1981-05-17 |
FI69474B FI69474B (fi) | 1985-10-31 |
FI69474C true FI69474C (fi) | 1986-02-10 |
Family
ID=26328728
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI803579A FI803579L (fi) | 1979-11-16 | 1980-11-14 | Nya 6alfa 9alfa-difluor-16-metyl-prednisolon 17,21-diestrar |
FI803577A FI803577L (fi) | 1979-11-16 | 1980-11-14 | Nya 6alfa-fluor-prednisolon 17,21-diestrar |
FI803578A FI69474C (fi) | 1979-11-16 | 1980-11-14 | Foerfarande att framstaella anti-inflammatoriska 6alfa-fluor-9alfa-klor-prednisolon 17,21-diestrar |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI803579A FI803579L (fi) | 1979-11-16 | 1980-11-14 | Nya 6alfa 9alfa-difluor-16-metyl-prednisolon 17,21-diestrar |
FI803577A FI803577L (fi) | 1979-11-16 | 1980-11-14 | Nya 6alfa-fluor-prednisolon 17,21-diestrar |
Country Status (12)
Country | Link |
---|---|
US (2) | US4358445A (no) |
EP (3) | EP0030615B1 (no) |
AU (3) | AU531292B2 (no) |
CA (3) | CA1162533A (no) |
DE (3) | DE3069074D1 (no) |
DK (3) | DK487580A (no) |
ES (3) | ES496839A0 (no) |
FI (3) | FI803579L (no) |
IE (1) | IE50829B1 (no) |
NO (3) | NO803450L (no) |
PH (2) | PH17696A (no) |
YU (3) | YU291380A (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0095894A3 (en) * | 1982-05-31 | 1985-01-02 | Ohta Seiyaku Kabushiki Kaisha. | 6 alpha-methylprednisolone derivatives |
PT78973A (en) * | 1984-07-25 | 1984-08-01 | Joao Emerico Villax | New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid |
US5110809A (en) * | 1988-03-21 | 1992-05-05 | Bristol-Myers Squibb Company | Antifungal gel formulations |
US6565885B1 (en) * | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
US20060165606A1 (en) * | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
CA2473471A1 (en) * | 2001-11-29 | 2003-06-12 | Taro Pharmaceuticals U.S.A., Inc. | Method for the preparation of 6-alpha-fluoro corticosteroids |
CN101759760B (zh) * | 2008-11-28 | 2013-02-13 | 天津金耀集团有限公司 | 一种含氟甾体激素的制备 |
CN101928318A (zh) * | 2009-06-24 | 2010-12-29 | 天津金耀集团有限公司 | 一种含氟甾体激素的制备 |
WO2011151941A1 (ja) | 2010-06-04 | 2011-12-08 | 国立大学法人東京大学 | 制御性t細胞の増殖または集積を誘導する作用を有する組成物 |
US10238694B2 (en) | 2011-12-01 | 2019-03-26 | The University Of Tokyo | Human-derived bacteria that induce proliferation or accumulation of regulatory T cells |
EP3019181A4 (en) | 2013-07-09 | 2016-09-21 | Puretech Ventures Llc | COMPOSITIONS CONTAINING COMBINATIONS OF BIOACTIVE MICROFLORE DERIVED MOLECULES FOR THE TREATMENT OF DISEASE |
CN108727458A (zh) * | 2018-05-10 | 2018-11-02 | 浙江仙居仙乐药业有限公司 | 一种17-丙酸酯的合成方法 |
CN112851734B (zh) * | 2019-11-27 | 2024-02-06 | 重庆华邦胜凯制药有限公司 | 一种二丙酸倍他米松的制备方法 |
CN111944002A (zh) * | 2020-07-29 | 2020-11-17 | 河南利华制药有限公司 | 一种倍氯米松二丙酸酯中间体及制备方法 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL241055A (no) * | 1958-07-09 | |||
US3499016A (en) * | 1958-08-04 | 1970-03-03 | Upjohn Co | 6alpha-fluoro-16alpha-methyl derivatives of the pregnane series |
GB933859A (no) * | 1958-09-06 | 1963-08-14 | Syntex S.A. | |
US3007923A (en) * | 1959-01-22 | 1961-11-07 | Lab Francais Chimiotherapie | Process for the fluorination of 9beta, 11beta-epoxy and 5alpha, 6alpha-epoxy steroids |
DE1081153B (de) * | 1959-01-23 | 1960-05-05 | Telefunken Gmbh | Verfahren zur Bepastung der Emissionsschichttraeger von Flachkathoden mit Emissionsmaterial und Vorrichtung zur Durchfuehrung des Verfahrens |
US3714353A (en) * | 1959-08-11 | 1973-01-30 | Upjohn Co | THERAPEUTIC COMPOSITIONS COMPRISING A 6 alpha ; 9 alpha -DIFLUORO-11 beta ,17 alpha ,21-TRIHYDROXY-16 alpha -METHYL-1,4-PREGNADIENE-3,20-DIONE AND 21-ACYLATES |
US3626063A (en) * | 1959-08-11 | 1971-12-07 | Upjohn Co | Therapeutic compositions comprising 6-fluoro-16-methyl prednisolone, the 21 acylates and salts thereof |
CH429716A (de) * | 1961-06-24 | 1967-02-15 | Vismara Francesco Spa | Verfahren zur Herstellung von 17a-Acyloxy-21-hydroxy-Steroiden |
GB1047518A (en) * | 1963-06-11 | 1966-11-02 | Glaxo Lab Ltd | 17ª-monoesters of 11,17,21-trihydroxy steroid compounds |
US3463852A (en) * | 1966-01-14 | 1969-08-26 | Schering Corp | Treating allergies with steroids of the pregnane series |
US3422193A (en) * | 1966-08-11 | 1969-01-14 | Schering Corp | 17-mono esters of corticoids |
IT1061787B (it) * | 1967-03-01 | 1983-04-30 | Vismara Francesco Spa | Miglioramenti relativi alla preparazione di 17 benzoato di betametazone |
US3780177A (en) * | 1967-06-16 | 1973-12-18 | Warner Lambert Co | 17-butyrate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use |
SE339685B (no) * | 1967-06-16 | 1971-10-18 | Warner Lambert Pharmaceutical | |
US3784692A (en) * | 1967-06-16 | 1974-01-08 | Warner Lambert Co | 17-propionate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use |
IT1034011B (it) * | 1969-06-26 | 1979-09-10 | Vister Vismara Terapeutici S P | Processo per la prapratzione di 17 monoesteri di 17 a 21 diossisteroidi per idrolisi die corpispondenti 17 21 ortoesteri ciclici a ph control lato |
DE2011559B2 (de) * | 1970-03-07 | 1973-03-08 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur herstellung von 9alpha-chlor-11beta-hydroxysteroiden |
US3691214A (en) * | 1970-06-08 | 1972-09-12 | Warner Lambert Pharmaceutical | 17-valerate ester of 6alpha,9alpha-difluoroprednisolone,its compositions and use as an anti-inflammatory agent |
US3857941A (en) * | 1970-06-22 | 1974-12-31 | Warner Lambert Co | Pharmaceutical compositions and use of prednisolone 17-benzoate |
DE2144405A1 (de) * | 1971-09-04 | 1973-03-08 | Merck Patent Gmbh | Verfahren zur herstellung von estern der pregnanreihe |
GB1403962A (en) | 1972-03-09 | 1975-08-28 | Upjohn Co | Anti-inflammatory pregnane derivative |
US3980778A (en) * | 1973-10-25 | 1976-09-14 | The Upjohn Company | Anti-inflammatory steroid |
DE2512915A1 (de) * | 1974-03-27 | 1975-10-09 | Plurichemie Anstalt | 16-methyl-9 alpha-halogen-steroide ester, aether und verfahren zu ihrer herstellung |
US4018918A (en) * | 1975-05-20 | 1977-04-19 | The Upjohn Company | Topical clindamycin preparations |
CH611631A5 (en) * | 1975-07-23 | 1979-06-15 | Ciba Geigy Ag | Process for the preparation of 11,12-unsaturated 9alpha-fluorosteroids |
US4036831A (en) * | 1975-10-28 | 1977-07-19 | Steroid Development Company Establishment | Trimethyl siloxane steroid intermediates |
LU75809A1 (no) * | 1976-09-16 | 1978-05-12 | ||
NL187577C (nl) | 1978-04-05 | 1991-11-18 | Sibla Srl | 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen. |
US4261984A (en) * | 1978-04-05 | 1981-04-14 | Syntex (U.S.A.) Inc. | 17β-thiocarboxylic acid esters of 3-oxo-4-halo-16β-methylandrost-4-enes |
-
1980
- 1980-11-03 EP EP80106721A patent/EP0030615B1/en not_active Expired
- 1980-11-03 DE DE8080106721T patent/DE3069074D1/de not_active Expired
- 1980-11-03 EP EP80106722A patent/EP0029151B1/en not_active Expired
- 1980-11-03 DE DE8080106720T patent/DE3068965D1/de not_active Expired
- 1980-11-03 DE DE8080106722T patent/DE3071122D1/de not_active Expired
- 1980-11-03 EP EP80106720A patent/EP0029924B1/en not_active Expired
- 1980-11-14 CA CA000364753A patent/CA1162533A/en not_active Expired
- 1980-11-14 ES ES496839A patent/ES496839A0/es active Granted
- 1980-11-14 YU YU02913/80A patent/YU291380A/xx unknown
- 1980-11-14 AU AU64389/80A patent/AU531292B2/en not_active Ceased
- 1980-11-14 AU AU64390/80A patent/AU530348B2/en not_active Ceased
- 1980-11-14 ES ES496841A patent/ES496841A0/es active Granted
- 1980-11-14 NO NO803450A patent/NO803450L/no unknown
- 1980-11-14 PH PH24862A patent/PH17696A/en unknown
- 1980-11-14 DK DK487580A patent/DK487580A/da not_active Application Discontinuation
- 1980-11-14 PH PH24861A patent/PH19406A/en unknown
- 1980-11-14 YU YU02911/80A patent/YU291180A/xx unknown
- 1980-11-14 AU AU64388/80A patent/AU530802B2/en not_active Ceased
- 1980-11-14 NO NO803451A patent/NO154268C/no unknown
- 1980-11-14 FI FI803579A patent/FI803579L/fi not_active Application Discontinuation
- 1980-11-14 NO NO803452A patent/NO803452L/no unknown
- 1980-11-14 DK DK487480A patent/DK487480A/da not_active Application Discontinuation
- 1980-11-14 ES ES496840A patent/ES8200121A1/es not_active Expired
- 1980-11-14 YU YU2912/80A patent/YU41747B/xx unknown
- 1980-11-14 DK DK487680A patent/DK487680A/da not_active Application Discontinuation
- 1980-11-14 CA CA000364755A patent/CA1162532A/en not_active Expired
- 1980-11-14 CA CA000364754A patent/CA1162921A/en not_active Expired
- 1980-11-14 FI FI803577A patent/FI803577L/fi not_active Application Discontinuation
- 1980-11-14 IE IE2379/80A patent/IE50829B1/en unknown
- 1980-11-14 FI FI803578A patent/FI69474C/fi not_active IP Right Cessation
- 1980-11-17 US US06/207,809 patent/US4358445A/en not_active Expired - Lifetime
-
1982
- 1982-03-23 US US06/361,119 patent/US4576936A/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI69474C (fi) | Foerfarande att framstaella anti-inflammatoriska 6alfa-fluor-9alfa-klor-prednisolon 17,21-diestrar | |
EP0057401B1 (en) | Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them | |
EP0004773B1 (en) | 17-beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes, their pharmaceutical use and processes for their preparation | |
US4124707A (en) | 7α-Halogeno-3,20-dioxo-1,4-pregnadienes, methods for their manufacture, their use as anti-inflammatory agents, and pharmaceutical formulations useful therefor | |
US4267173A (en) | Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor | |
US4076708A (en) | Process for the preparation of 7α-halogeno-3-oxo-4-dehydro steroids and novel 7α-halogeno derivatives produced thereby | |
CA1056371A (en) | Polyhalogeno-steroids and processes for their manufacture | |
EP0004741A2 (en) | Thio etianic acid derivatives, their preparation and pharmaceutical use | |
US2831003A (en) | Cycloborate esters of 16alpha, 17alpha-dihydroxy steroids | |
IE43452B1 (en) | Terpenoid esters of steroids | |
CA1101410A (en) | Polyhalogenated steroids | |
US2867636A (en) | 6-methyl-9alpha, 21 difluoro-11 oxygenated 17alpha hydroxy-1, 4 pregnadiene-3, 20 dione steroid compounds | |
US3707537A (en) | 4-chloro-4,6-diene-6-halo or lower alkyl steroids | |
KR840000747B1 (ko) | 6α-플루오로-9α-클로로프레드니솔론 17, 21-디에스테르의 제조방법 | |
HU201092B (en) | Process for producing new corticosteroid derivatives and pharmaceutical compositions comprising same | |
US3980680A (en) | Process for the preparation of 21-desoxy-17-acyloxy-4-pregnenes and of 21-iodo-21-desoxy-17-acyl oxy-4-pregnene intermediates useful therein | |
FI63947B (fi) | Foerfarande foer framstaellning av farmakologiskt vaerdefulla 3,20-dioxo-7alfa-halogen-4-pregnener och 1,4-pregnadiener | |
KR810000311B1 (ko) | 7-할로-3,20-디옥소-1,4-프레그나디엔 및 -4-프레그넨의 제조 방법 | |
US3681338A (en) | C-21 lower alkysulfinyl esters of certain 6{60 -fluoro-21-hydroxycorticosteroids | |
US3673179A (en) | C-21 lower alkylsulfinyl esters of certain 21-hydroxycorticosteroids | |
NO791144L (no) | 4-halogenetansyre og derivater derav, samt fremgangsmaate til deres fremstilling | |
NO791143L (no) | 4,6-dihalogensteroider, og fremgangsmaate til deres fremstilling | |
NO153601B (no) | Anordning ved beholdere. | |
NO761516L (no) | Fremgangsm}te for fremstilling av steroider |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed |
Owner name: STEROSYNT LTD. |